In this study, we propose Nectin-4 as a potential biomarker for ovarian cancer that has high potential to improve the detection of ovarian cancer as part of a biomarker panel, in particular by identifying early stages of the disease. The gene discussed is NECTIN4; the disease is ovarian carcinoma.